INTERCEPT PHARMACEUTICALS, INC. Insider Trading for January 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. for January 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 22 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Option Exercise | M | 9.82 | 973 | 9,557 | 5,950 | |
Jan 22 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Sell | S | 151.32 | 973 | 147,234 | 1,465 | 2.4 K to 1.5 K (-39.91 %) |
Jan 22 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Buy | M | 9.82 | 973 | 9,557 | 2,438 | 1.5 K to 2.4 K (+66.42 %) |
Jan 14 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Option Exercise | M | 21.50 | 233 | 5,010 | 10,401 | |
Jan 14 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 150.01 | 233 | 34,952 | 2,166 | 2.4 K to 2.2 K (-9.71 %) |
Jan 14 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Buy | M | 21.50 | 233 | 5,010 | 2,399 | 2.2 K to 2.4 K (+10.76 %) |
Jan 07 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 176.49 | 146 | 25,767 | 1,264 | 1.4 K to 1.3 K (-10.35 %) |
Jan 07 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 176.49 | 461 | 81,360 | 491,032 | 491.5 K to 491 K (-0.09 %) |
Jan 07 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 172.63 | 664 | 114,627 | 14,648 | 15.3 K to 14.6 K (-4.34 %) |
Jan 07 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 176.49 | 141 | 24,884 | 17,264 | 17.4 K to 17.3 K (-0.81 %) |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 0.00 | 1,623 | 0 | 6,490 | |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 158.71 | 376 | 59,675 | 15,312 | 15.7 K to 15.3 K (-2.40 %) |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 0.00 | 1,623 | 0 | 15,688 | 14.1 K to 15.7 K (+11.54 %) |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 0.00 | 4,868 | 0 | 19,471 | |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 0.00 | 4,868 | 0 | 491,493 | 486.6 K to 491.5 K (+1.00 %) |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 31.90 | 1,000 | 31,900 | 14,875 | |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,298 | 0 | 5,192 | |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 158.35 | 500 | 79,175 | 17,405 | 17.9 K to 17.4 K (-2.79 %) |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 154.45 | 500 | 77,225 | 17,905 | 18.4 K to 17.9 K (-2.72 %) |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 31.90 | 1,000 | 31,900 | 18,405 | 17.4 K to 18.4 K (+5.75 %) |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 0.00 | 1,298 | 0 | 17,405 | 16.1 K to 17.4 K (+8.06 %) |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Option Exercise | M | 0.00 | 649 | 0 | 2,596 | |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Buy | M | 0.00 | 649 | 0 | 9,411 | 8.8 K to 9.4 K (+7.41 %) |